Prognostic role of KL‐6 in SSc‐ILD patients with pleuroparenchymal fibroelastosis
Sign Up to like & getrecommendations! Published in 2021 at "European Journal of Clinical Investigation"
DOI: 10.1111/eci.13543
Abstract: Krebs von den Lungen‐6 (KL‐6) is a high‐molecular‐weight (200kDa) glycoprotein proposed as a diagnostic biomarker for differentiating interstitial lung disease (ILD). Systemic sclerosis (SSc) is a rare immune‐mediated disorder, and ILD is the leading cause… read more here.
Keywords: role ssc; pleuroparenchymal fibroelastosis; ssc ild; ild patients ... See more keywords